Cargando…

Synthesis, Molecular Modeling, and Biological Evaluation of Novel Tetrahydro-β-Carboline Hydantoin and Tetrahydro-β-Carboline Thiohydantoin Derivatives as Phosphodiesterase 5 Inhibitors

Two series of fused tetrahydro-β-carboline hydantoin and tetrahydro-β-carboline thiohydantoin derivatives with a pendant 2,4-dimethoxyphenyl at position 5 were synthesized, and chiral carbons at positions 5 and 11a swing from R,R to R,S, S,R, and S,S. The prepared analogues were evaluated for their...

Descripción completa

Detalles Bibliográficos
Autores principales: Abadi, Ashraf H., Lehmann, Jochen, Piazza, Gary A., Abdel-Halim, Mohammad, Ali, Mohamed S. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939265/
https://www.ncbi.nlm.nih.gov/pubmed/27471602
http://dx.doi.org/10.1155/2011/562421
_version_ 1782441982283481088
author Abadi, Ashraf H.
Lehmann, Jochen
Piazza, Gary A.
Abdel-Halim, Mohammad
Ali, Mohamed S. M.
author_facet Abadi, Ashraf H.
Lehmann, Jochen
Piazza, Gary A.
Abdel-Halim, Mohammad
Ali, Mohamed S. M.
author_sort Abadi, Ashraf H.
collection PubMed
description Two series of fused tetrahydro-β-carboline hydantoin and tetrahydro-β-carboline thiohydantoin derivatives with a pendant 2,4-dimethoxyphenyl at position 5 were synthesized, and chiral carbons at positions 5 and 11a swing from R,R to R,S, S,R, and S,S. The prepared analogues were evaluated for their capacity to inhibit phosphodiesterase 5 (PDE5) isozyme. The R absolute configuration of C-5 in the β-carboline hydantoin derivatives was found to be essential for the PDE5 inhibition. Chiral carbon derived from amino acid even if of the S configuration (L-tryptophan) may lead to equiactive or more active isomers than those derived from amino acid with the R configuration (D-tryptophan). This expands the horizon from which efficient PDE5 inhibitors can be derived and may offer an economic advantage. The thiohydantoin derivatives were less active than their hydantoin congeners.
format Online
Article
Text
id pubmed-4939265
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-49392652016-07-28 Synthesis, Molecular Modeling, and Biological Evaluation of Novel Tetrahydro-β-Carboline Hydantoin and Tetrahydro-β-Carboline Thiohydantoin Derivatives as Phosphodiesterase 5 Inhibitors Abadi, Ashraf H. Lehmann, Jochen Piazza, Gary A. Abdel-Halim, Mohammad Ali, Mohamed S. M. Int J Med Chem Research Article Two series of fused tetrahydro-β-carboline hydantoin and tetrahydro-β-carboline thiohydantoin derivatives with a pendant 2,4-dimethoxyphenyl at position 5 were synthesized, and chiral carbons at positions 5 and 11a swing from R,R to R,S, S,R, and S,S. The prepared analogues were evaluated for their capacity to inhibit phosphodiesterase 5 (PDE5) isozyme. The R absolute configuration of C-5 in the β-carboline hydantoin derivatives was found to be essential for the PDE5 inhibition. Chiral carbon derived from amino acid even if of the S configuration (L-tryptophan) may lead to equiactive or more active isomers than those derived from amino acid with the R configuration (D-tryptophan). This expands the horizon from which efficient PDE5 inhibitors can be derived and may offer an economic advantage. The thiohydantoin derivatives were less active than their hydantoin congeners. Hindawi Publishing Corporation 2011 2011-02-23 /pmc/articles/PMC4939265/ /pubmed/27471602 http://dx.doi.org/10.1155/2011/562421 Text en Copyright © 2011 Ashraf H. Abadi et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Abadi, Ashraf H.
Lehmann, Jochen
Piazza, Gary A.
Abdel-Halim, Mohammad
Ali, Mohamed S. M.
Synthesis, Molecular Modeling, and Biological Evaluation of Novel Tetrahydro-β-Carboline Hydantoin and Tetrahydro-β-Carboline Thiohydantoin Derivatives as Phosphodiesterase 5 Inhibitors
title Synthesis, Molecular Modeling, and Biological Evaluation of Novel Tetrahydro-β-Carboline Hydantoin and Tetrahydro-β-Carboline Thiohydantoin Derivatives as Phosphodiesterase 5 Inhibitors
title_full Synthesis, Molecular Modeling, and Biological Evaluation of Novel Tetrahydro-β-Carboline Hydantoin and Tetrahydro-β-Carboline Thiohydantoin Derivatives as Phosphodiesterase 5 Inhibitors
title_fullStr Synthesis, Molecular Modeling, and Biological Evaluation of Novel Tetrahydro-β-Carboline Hydantoin and Tetrahydro-β-Carboline Thiohydantoin Derivatives as Phosphodiesterase 5 Inhibitors
title_full_unstemmed Synthesis, Molecular Modeling, and Biological Evaluation of Novel Tetrahydro-β-Carboline Hydantoin and Tetrahydro-β-Carboline Thiohydantoin Derivatives as Phosphodiesterase 5 Inhibitors
title_short Synthesis, Molecular Modeling, and Biological Evaluation of Novel Tetrahydro-β-Carboline Hydantoin and Tetrahydro-β-Carboline Thiohydantoin Derivatives as Phosphodiesterase 5 Inhibitors
title_sort synthesis, molecular modeling, and biological evaluation of novel tetrahydro-β-carboline hydantoin and tetrahydro-β-carboline thiohydantoin derivatives as phosphodiesterase 5 inhibitors
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939265/
https://www.ncbi.nlm.nih.gov/pubmed/27471602
http://dx.doi.org/10.1155/2011/562421
work_keys_str_mv AT abadiashrafh synthesismolecularmodelingandbiologicalevaluationofnoveltetrahydrobcarbolinehydantoinandtetrahydrobcarbolinethiohydantoinderivativesasphosphodiesterase5inhibitors
AT lehmannjochen synthesismolecularmodelingandbiologicalevaluationofnoveltetrahydrobcarbolinehydantoinandtetrahydrobcarbolinethiohydantoinderivativesasphosphodiesterase5inhibitors
AT piazzagarya synthesismolecularmodelingandbiologicalevaluationofnoveltetrahydrobcarbolinehydantoinandtetrahydrobcarbolinethiohydantoinderivativesasphosphodiesterase5inhibitors
AT abdelhalimmohammad synthesismolecularmodelingandbiologicalevaluationofnoveltetrahydrobcarbolinehydantoinandtetrahydrobcarbolinethiohydantoinderivativesasphosphodiesterase5inhibitors
AT alimohamedsm synthesismolecularmodelingandbiologicalevaluationofnoveltetrahydrobcarbolinehydantoinandtetrahydrobcarbolinethiohydantoinderivativesasphosphodiesterase5inhibitors